VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts23232626
Avg. Estimate3.63.6413.5814.92
Low estimate3.232.8212.0312.58
High estimate4.134.3315.2418.16
Year ago EPS3.64.0114.8813.58
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts25243030
Avg. Estimate2.26B2.29B9.1B9.77B
Low estimate2.21B2.11B8.95B8.87B
High estimate2.31B2.4B9.4B10.73B
Year ago sales2.2B2.23B8.93B9.1B
Sales growth (year/est)2.80%2.80%1.90%7.40%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS3.483.643.512.79
Actual EPS3.64.013.762.84
Difference0.120.370.250.05
Surprise %3.40%10.20%7.10%1.80%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate3.63.6413.5814.92
7 days ago3.623.6613.6415.04
30 days ago3.893.9314.6316.05
60 days ago3.663.814.2615.49
90 days ago3.673.8114.2815.47
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A32
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVRTXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.-9.20%N/AN/AN/A
Current year-8.70%N/AN/AN/A
Next year9.90%N/AN/AN/A
Next 5 years (per annum)7.64%N/AN/AN/A
Past 5 years (per annum)37.95%N/AN/AN/A